March 18, 2013
I have just finished my third week of treatment, although technically, a clinical trial isn’t treatment—it only becomes that after we know it works and the drugs are approved. However, I have a certainty in me, a certainty that I had both times I was treated before. My style is to assume that I will [...]
Read the full article →
February 20, 2012
The HCV protease inhibitors (Incivek and Victrelis) have been out for less than a year. These drugs raise new issues, particularly the risk of developing resistance. Interactions with other drugs and supplements are a new problem that was not a major concern with combination peginterferon and ribavirin. These new drugs increase the risk of certain [...]
Read the full article →
